Position in NERV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,920,864
-$4,886,310 QoQ
Shares Held
4,670,426
-8.7% QoQ
Ownership
9.78%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 58 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. NERV ranks #30 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in NERV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,920,864 | 4,670,426 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $30,807,174 | 5,113,224 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $21,594,535 | 5,371,775 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,844,433 | 1,351,275 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,324,193 | 1,351,275 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,297,167 | 1,351,275 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $3,002,533 | 1,351,275 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,607,904 | 1,351,275 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,310,567 | 1,351,275 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,486,289 | 1,351,275 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,310,341 | 1,351,275 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $9,323,797 | 1,351,275 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,350,653 | 1,351,275 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,922,040 | 1,201,275 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $1,910,027 | 1,201,275 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,087,768 | 1,201,275 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,976,220 | 1,201,275 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $7,976,466 | 9,610,200 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,697,770 | 9,610,200 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,721,748 | 9,610,200 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $22,295,664 | 9,610,200 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $28,061,784 | 9,610,200 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $22,487,868 | 9,610,200 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $30,560,436 | 9,610,200 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $34,692,822 | 9,610,200 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $57,853,404 | 9,610,200 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||